Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Cancer Biology & Medicine|May 26, 2021
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancerDenise Drago, Annapaola Andolfo, Ettore Mosca, et al.
Cancer Research|February 28, 2002
Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cellsPaola Castiglioni, Alfonso Martin-Fontecha, Gabriella Milan, et al.
Molecular Cancer Therapeutics|December 17, 2008
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgammaAnna Maria Gasparri, Elena Jachetti, Barbara Colombo, et al.
Oncoimmunology|May 6, 2015
A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanomaGiorgio Parmiani, Lorenzo Pilla, Angelo Corti, et al.
Cancer Research|June 11, 2013
Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantationRodrigo Hess Michelini, Teresa Manzo, Tabea Sturmheit, et al.
Cancer Research|January 4, 2008
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cellsElena Degl'Innocenti, Matteo Grioni, Giusy Capuano, et al.
Stem Cells Translational Medicine|July 26, 2013
Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumorsStefania Mazzoleni, Elena Jachetti, Sara Morosini, et al.
The Prostate|April 26, 2008
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancerMaria T S Bertilaccio, Matteo Grioni, Brent W Sutherland, et al.
Oncoimmunology|June 14, 2013
Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesElena Jachetti, Stefania Mazzoleni, Matteo Grioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Characterization of preclinical models of prostate cancer using PET-based molecular imagingSara Belloli, Elena Jachetti, Rosa M Moresco, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Biology & Medicine|May 26, 2021
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancerDenise Drago, Annapaola Andolfo, Ettore Mosca, et al.
Cancer Research|February 28, 2002
Apoptosis-dependent subversion of the T-lymphocyte epitope hierarchy in lymphoma cellsPaola Castiglioni, Alfonso Martin-Fontecha, Gabriella Milan, et al.
Molecular Cancer Therapeutics|December 17, 2008
Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgammaAnna Maria Gasparri, Elena Jachetti, Barbara Colombo, et al.
Oncoimmunology|May 6, 2015
A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanomaGiorgio Parmiani, Lorenzo Pilla, Angelo Corti, et al.
Cancer Research|June 11, 2013
Vaccine-instructed intratumoral IFN-γ enables regression of autochthonous mouse prostate cancer in allogeneic T-cell transplantationRodrigo Hess Michelini, Teresa Manzo, Tabea Sturmheit, et al.
Cancer Research|January 4, 2008
Peripheral T-cell tolerance associated with prostate cancer is independent from CD4+CD25+ regulatory T cellsElena Degl'Innocenti, Matteo Grioni, Giusy Capuano, et al.
Stem Cells Translational Medicine|July 26, 2013
Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumorsStefania Mazzoleni, Elena Jachetti, Sara Morosini, et al.
The Prostate|April 26, 2008
Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancerMaria T S Bertilaccio, Matteo Grioni, Brent W Sutherland, et al.
Oncoimmunology|June 14, 2013
Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responsesElena Jachetti, Stefania Mazzoleni, Matteo Grioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Characterization of preclinical models of prostate cancer using PET-based molecular imagingSara Belloli, Elena Jachetti, Rosa M Moresco, et al.
Pageof 9